Paper - WANFANG MED ONLINE

You Position: Home > Paper

Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis

( views:180, downloads:64 )

Author:: No author available

Journal Title:: Chinese Journal of Clinical Infectious Diseases

Issue:: 4

DOI:: 10.3760/cma.j.issn.1674-2397.2015.04.023

Key Word:: 脑室腹膜分流术;葡萄球菌,表皮;中枢神经系统感染;Ventriculoperitoneal shunt;Staphylococcus epidermidis;Central nervous system infections

Abstract： Staphylococcus epidermidis has the ability to adhere to the surface of shunt tube and to develop the biofilm .It can embed itself in the biofilm so as to escape from the defense of the host .Due to the presence of biofilms , antimicrobial drug resistance , blood brain barrier of central nervous system , the treatment of shunt-related infection caused by Staphylococcus epidermidis is very difficult.This paper reviews the risk factors , prevalence , pathogenesis , treatment and prevention of ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis.

Reference

[1]马向科,顾征,李彤.脑室腹腔分流术后颅内感染的诊治体会[J].2011,(5).
[2]McGirt, Matthew J.,Zaas, Aimee,Fuchs, Herbert E.,etc.Risk Factors for Pediatric Ventriculoperitoneal Shunt Infection and Predictors of Infectious Pathogens.[J].2003,36(7).
[3]Rainer, Ritz,Florian, Roser,Matthias, Morgalla,etc.Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.[J].2007,7.
[4]孙连军.脑室-腹腔分流术后感染26例诊治分析[J].2012,(4).
[5]Nau R,Sorgel F,Eiffert H.Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.[J].2010,23(4).
[6]Jabbouri S,O'Gara JP,Humphreys H,etc.Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2[J].2009,11(3).
[7]Mark E, Rupp.Clinical Characteristics of Infections in Humans Due to Staphylococcus epidermidis.[J].2014,1106.
[8]Jones,J.E.,Sun,H.,Chen,M.,etc.Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating[J].2012,56(11).
[9]Gerard Lina,Mario Recker,Ruth C. Massey,etc.The evolution and maintenance of virulence in Staphylococcus aureus: a role for host-to-host transmission?[J].2006,4(12).
[10]Naomi P. O'Grady,Mary Alexander,E. Patchen Dellinger,etc.Guidelines for the Prevention of Intravascular Catheter-Related Infections[J].2002,51.
[11]O'Gara,J.P.,Sattar,M.T.A.,Stevens,N.T.,etc.Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: Pathogenesis and implications for treatment[J].2012,26(6).
[12]Otto M.Targeted Immunotherapy for Staphylococcal Infections: Focus on Anti-MSCRAMM Antibodies.[J].2008,22(1).
[13]Sadovskaya I,Ramasubbu N,Kaplan JB,etc.Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition[J].2007,75(1).
[14]W E, Whitehead,J R, Kestle.The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons.[J].2001,35(4).
[15]O'Gara JP,Kennedy CA,Fitzpatrick F,etc.Environmental regulation of biofilm formation in intensive care unit isolates of Staphylococcus epidermidis.[J].2002,52(3).
[16]N U Owase, Jeelani,Abhaya V, Kulkarni,Pani, Desilva,etc.Postoperative cerebrospinal fluid wound leakage as a predictor of shunt infection: a prospective analysis of 205 cases. Clinical article.[J].2009,4(2).
[17]Kulkarni AV,Lamberti-Pasculli M,Drake JM.Cerebrospinal fluid shunt infection: a prospective study of risk factors.[J].2001,94(2).
[18]J R, Kestle,H J, Hoffman,D, Soloniuk,etc.A concerted effort to prevent shunt infection.[J].1993,9(3).
[19]Simon M,Volz S,Heep A,etc.Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children.[J].2009,45(5).
[20]陈大刚,张艳蕉,赵静.脑室-腹腔分流术后颅内感染的病原学分析及抗菌药物优化治疗[J].2014,(3).
[21]Vuong C,Durr M,Otto M,etc.Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins[J].2004,6(8).
[22]Simon,T.D.,Butler,J.,Whitlock,K.B.,etc.Risk factors for first cerebrospinal fluid shunt infection: Findings from a multi-center prospective cohort study[J].2014,164(6).
[23]Kan P,Kestle J.Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children.[J].2007,23(7).
[24]Gutierrez-Murgas,Y.,Snowden,J.N..Ventricular shunt infections: Immunopathogenesis and clinical management[J].2014,276(1/2).
[25]Kocianova S,Yao Y,Carmody AB,etc.Increased Colonization of Indwelling Medical Devices by Quorum-Sensing Mutants of Staphylococcus epidermidis In Vivo.[J].2004,190(8).
[26]Hussain M.,Heilmann C.,Gotz F.,etc.Evidence for Autolysin-Mediated Primary Attachment of Staphylococcus Epidermidis to a Polystyrene Surface[J].1997,24(5).
[27]Megan R. Kiedrowski,Alexander R. Horswill.New approaches for treating staphylococcal biofilm infections[J].2011,1241.
[28]Hall Stoodley L,Quigley M,Braxton EE Jr,etc.Role of biofilms in neurosurgical device-related infections.[J].2005,28(4).
[29]F. Gomes,P. Teixeira,R. Oliveira.Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies[J].2014,30(1).
[30]Olson ME,Fey PD.Current concepts in biofilm formation of Staphylococcus epidermidis.[J].2010,5(6).
[31]G, O'Toole,H B, Kaplan,R, Kolter.Biofilm formation as microbial development.[J].2000,54.
[32]Vuong C,Somerville GA,Fischer ER,etc.Quorum-Sensing Control of Biofilm Factors in Staphylococcus epidermidis.[J].2003,188(5).
[33]Holger, Heine,Artur J, Ulmer.Recognition of bacterial products by toll-like receptors.[J].2005,86.
[34]Jabbouri S,Sadovskaya I.Characteristics of the biofilm matrix and its role as a possible target for the detection and eradication of Staphylococcus epidermidis associated with medical implant infections.[J].2010,59(3).
[35]Tamara D, Simon,Matthew, Hall,Jay, Riva-Cambrin,etc.Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.[J].2009,4(2).
[36]Arciola CR.New concepts and new weapons in implant infections.[J].2009,32(9).
[37]Adem, Yilmaz,Nazan, Dalgic,Murat, Müslüman,etc.Linezolid treatment of shunt-related cerebrospinal fluid infections in children.[J].2010,5(5).
[38]Kestle JR,Walker ML,Luerssen TG,etc.A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative.[J].2011,8(1).
[39]Rahel, Decker,Christoph, Burdelski,Melanie, Zobiak,etc.An 18 kDa scaffold protein is critical for Staphylococcus epidermidis biofilm formation.[J].2015,11(3).
[40]Seymour J.Klebanoff,D.Shane O'Mahony,David M.Underhill,etc.Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin[J].2001,166(1).
[41]D, Mack,M, Haeder,N, Siemssen,etc.Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin.[J].1996,174(4).
[42]Michael Otto.Molecular basis of Staphylococcus epidermidis infections.[J].2012,34(2).
[43]Conlon, Kevin M.,Humphreys, Hilary,O'Gara, James P..IcaR Encodes a Transcriptional Repressor Involved in Environmental Regulation of ica Operon Expression and Biofilm Formation in Staphylococcus epidermidis.[J].2002,184(16).
[44]Otto M.Staphylococcus aureus and Staphylococcus epidermidis peptide pheromones produced by the accessory gene regulator agr system.[J].2001,22(10).
[45]Bollam,P.,Caldito,G.,Reddy,G.K..Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: Long-term single institution experience[J].2012,78(1).
[46]Christner M,Aepfelbacher M,Ruckdeschel K,etc.Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A.1.[J].2011,79(6).
[47]Michael Otto.Staphylococcus epidermidis-the ‘accidental’ pathogen[J].2009,7(8).
[48]Sabatino G,Capone G,Maira G,etc.Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection.[J].2009,151(10).